Posts for BRIGHT MINDS BIOSCIENCES INC. ($DRUG)

Showing 1 - 3 of 3 Posts

Bright Minds Biosciences Inc. 6-K Filing: Key Insights & Compliance Report

$DRUG

•

6-K

•

2025-02-24

Last updated: 9 months ago

Bright Minds Biosciences Inc. 6-K Filing: Key Insights & Compliance Report

Discover Bright Minds Biosciences Inc.'s Form 6-K filing details, including insights on compliance, exhibits, and financial updates as of February 24, 2025.

Bright Minds Biosciences Form 6-K financial disclosures Securities Exchange Act biotechnology sector

Bright Minds Biosciences Inc. February 2025 Financial Report Highlights

$DRUG

•

6-K

•

2025-02-14

Last updated: 10 months ago

Bright Minds Biosciences Inc. February 2025 Financial Report Highlights

Explore Bright Minds Biosciences Inc.'s Form 6-K, detailing Q1 2024 financials, management insights, and CEO/CFO certifications.

Bright Minds Biosciences biotechnology sector financial report analysis Form 6-K investor relations

Bright Minds Biosciences Inc. Form 6-K Report: Key Updates & Compliance Insights

$DRUG

•

6-K

•

2025-01-08

Last updated: 11 months ago

Bright Minds Biosciences Inc. Form 6-K Report: Key Updates & Compliance Insights

Discover Bright Minds Biosciences Inc.'s latest Form 6-K filing, highlighting significant events, annual report intentions, and a key news release from January 7, 2025.

Bright Minds Biosciences Form 6-K financial reporting SEC compliance biotechnology sector

Financial Reports and Analysis for BRIGHT MINDS BIOSCIENCES INC. | SECsense